Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy
Abstract Identifying reliable prognostic markers in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) is critical for clinical decision-making. This study introduces the Metabolic and Immune Score (MIS), a novel scoring system combining metabo...
Saved in:
| Main Authors: | Beliz Bahar Karaoğlan, Ecenur Dursun, İrem Mesci, Mine Soylu Araz, Elif Berna Köksoy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-16788-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation and modifcation of lung immune prognostic index in patients with metastatic NSCLC treated by immunotherapy
by: D. I. Yudin, et al.
Published: (2023-05-01) -
Prognostic model integrating histology, systemic inflammation, and recurrence status predicts immunotherapy response in advanced non-small-cell lung cancer patients
by: F. V. Moiseenko, et al.
Published: (2025-07-01) -
Is adjuvant immunotherapy necessary after neoadjuvant chemoimmunotherapy in patients with resectable stage III NSCLC? A two-center real-world study
by: Song Guan, et al.
Published: (2025-07-01) -
Evaluating the efficacy of neoadjuvant immunotherapy combined with chemotherapy for stage IIIa non-small cell lung cancer
by: Ruiqiang Song, et al.
Published: (2025-07-01) -
Exploring fecal microbiota signatures associated with immune response and antibiotic impact in NSCLC: insights from metagenomic and machine learning approaches
by: Wenjie Han, et al.
Published: (2025-07-01)